A recent post-hoc analysis of the SURMOUNT-OSA trials revealed that tirzepatide significantly improves obstructive sleep ...

Interim analysis of real-world REFRESH study demonstrated clinically significant efficacy and improvement of EDS for patients who switched from twice-nightly oxybate to once-at-bedtime LUMRYZ – – Data ...

Obstructive Sleep Apnea (OSA) remains a widespread yet under-treated condition, affecting millions globally. Traditional treatments such as CPAP therapy, w | Drug Discovery And Development ...

Topline data were announced from a phase 3 trial evaluating AD109 (aroxybutynin 2.5mg/atomoxetine 75mg) in participants with obstructive sleep apnea.

There are few sex differences in narcolepsy type 1 symptom onset, but women have longer sleep times, higher efficiency, and men have higher BMI.

The index’s scale runs from 0 to 500; the higher the number, the worse the air. If the index is registering less than 100, then the air pollution at that location is considered below the level ...

Such apnea-hypopneas are measured utilizing the apneas-hypopnea index (AHI). This has been defined as the number of apneic or hypopneic events divided by total hours of sleep. AHI values which are ...

Obstructive sleep apnea severity measured via apnea-hypopnea index decreased among patients receiving AD109, an oral combination drug, for 26 weeks, according to phase 3 SynAIRgy trial topline ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Our research team assigns Gold ratings to strategies that they have the most conviction will outperform a relevant index, or most peers ... distribution network, scale, established brand, and ...

The CAC 40 (Cotation Assistée en Continu) is the leading index of the Paris stock exchange and is regarded as a market indicator for the general retail trends on the Euronext Paris stock exchange.